iPharma TIRZEPSEMA 34mg Pen
Combination of 30mg Tirzepatide + 4mg Semaglutide in One Powerful Pen
The iPharma TirzepSema 34mg Pen blends two advanced GLP-1 receptor agonists into a single high-performance weekly injection. This dual-action formula offers deeper appetite suppression, smoother metabolic control, and faster fat-loss results than using either ingredient alone.
Perfect for clients who want a stronger, synergistic GLP option.
HOW TIRZEPSEMA WORKS
Tirzepatide (30mg) – GLP-1 + GIP Dual Agonist
Powerfully suppresses appetite
Reduces cravings
Supports strong fat-loss
Enhances insulin sensitivity
Helps regulate blood sugar

Semaglutide (4mg) – GLP-1 Agonist
Slows gastric emptying (keeps you full longer)
Reduces food noise
Compliments tirzepatide with smoother appetite control
Improves satiety and portion control

Combined Effect = Faster, Deeper and Smoother Weight Loss
The two peptides strengthen each other, giving stronger results than using them individually.
STANDARD DOSAGE PROTOCOL
Exactly matched to the dosage block in your image.
Week 1–4:
2.75mg per week
Week 5–8:
5.5mg per week
Week 9–12:
8.25mg per week
Week 13+:
11mg per week

IMPORTANT DOSING NOTES
Minimum 4 weeks per dosage strength
If side effects are too strong, you can do smaller increases
Example: increase by 5 clicks instead of 10 clicks every 4 weeks
If a dose works well, you may stay on that level as long as appetite is under control
 
WHAT DOES TIRZEPSEMA DO?
Reduces appetite and increases fullness
Improves blood sugar control
Reduces cravings and food noise
Improves insulin levels
Enhances metabolic health
Supports significant weekly weight loss

COMMON SIDE EFFECTS (Client-Friendly)
May include:
• Nausea / vomiting / fatigue
• Diarrhea / constipation / abdominal pain
• Gas / bloating / belching
• Headache / dizziness
• Heartburn / reflux
• General stomach discomfort
Most people don’t experience every side effect. They usually reduce as your body adjusts.